Journal of the American College of Cardiology, Volume 85, Issue 10, 1 1 2025, Pages 1042-1055 Best Practices for Imaging of Transcatheter Valve Failure: An Update From the Heart Valve Collaboratory. Khalique OK, Zaid S, Tang GHL, Abdel-Wahab M, Akodad M, Bapat VN, Bax JJ, Blackman DJ, Blanke P, Bleiziffer S, Capodanno D, Cavalcante JL, Dasi LP, De Backer O, De Beuel M, Duncan A, Dweck MR, Fukui M, Gupta A, Hayashida K, Herrmann HC, Kaneko T, Karam N, Khan JM, Kovac J, Landes U, Leipsic JA, Leon MB, Mack MJ, Madhavan MV, Makar MM, Makkar RR, Al Mallah M, Meier D, Modine T, Okada A, Parikh RK, Parma R, Patel D, Pibarot P, Prendergast B, Quader N, Reardon MJ, Rogers T, Safi LM, Sellers SL, Skaf S, Tarantini G, Tchetche D, van Mieghem N, Wang DD, Webb JG, Windecker S, Yakubov SJ, Delgado V, Hahn RT, Jilaihawi H
This updated Heart Valve Collaboratory framework addresses the growing concern for transcatheter valve failure (TVF) following transcatheter aortic valve replacement (TAVR). With the increasing volume of redo-TAV and surgical TAV explantation, there is a critical need for standardized pathways and protocols for evaluating TVF using echocardiography and cardiac computed tomography (CT) angiography. This document clarifies prior definitions of bioprosthetic valve deterioration and bioprosthetic valve failure in a practical, imaging directed context for TAVR. It discusses various imaging modalities for diagnosing TVF, including echocardiography, cardiac CT angiography, cardiac magnetic resonance, and positron emission tomography/CT. Recommendations are provided on the systematic imaging for: 1) follow-up post-TAVR; 2) procedural planning for redo-TAV; and 3) post-redo-TAV, emphasizing the importance of regular monitoring and the need for comprehensive imaging data to optimize patient outcomes in the lifetime management of aortic valve disease.
